Pivot Completes C$1.1 Million Non-Brokered Private Placement and Loan Facility
Appoints MNP LLP As Auditor VANCOUVER, March 7, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE:PVOT / OTCQB:PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that it has closed a non-brokered financing consisting of a Private Placement (the ... [Read]
Pivot Pharma Develops Transdermal Patch for Delivery of CBD and THC
Formulated Using Pivot's Thrudermic™ Transdermal Nanotechnology VANCOUVER, Feb. 15, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE:PVOT / OTCQB:PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that the Company has completed the development of a controlled-release transdermal patch ... [Read]
Pivot Pharma Signs Contract Manufacturing Agreement with Growpacker Inc.
Patented Topical Gels, Creams and Beverages to be Manufactured for California Market VANCOUVER, Jan. 28, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE:PVOT / OTCQB:PVOTF / FRA:NPAT) ("Pivot" or the "Company") is pleased to announce that the Company has entered ... [Read]
Pivot Secures Supply of Pharmaceutical Grade CBD Isolate from PURE Holding AG
Strategic Partnership Includes Distribution and Product Development Agreements VANCOUVER, Dec. 20, 2018 /CNW/ - Pivot Pharmaceuticals Inc. (CSE:PVOT / OTCQB:PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that the Company has signed a Definitive Agreement ("the Agreement") ... [Read]
Pivot Announces Completion of Definitive Agreement with Cartagena Inc.
New Entity to Commercialize Cannabis-Infused Beverages VANCOUVER, Dec. 18, 2018 /CNW/ - Pivot Pharmaceuticals Inc. (CSE:PVOT / OTCQB:PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to report that it has completed the previously announced transaction to create a Joint Venture Corporation ... [Read]
Pivot Naturals LLC Receives Three Additional Notices of Allowance from USPTO
Syndicated under license via QuoteMedia Further Solidifies Pivot's Ready-to-Infuse Cannabis Powderization Technology Portfolio VANCOUVER, Nov. 19, 2018 /CNW/ - Pivot Pharmaceuticals Inc. (CSE:PVOT / OTCQB:PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that its wholly-owned subsidiary, Pivot ... [Read]
Knol Resources and Pivot Pharmaceuticals Mutually Terminate Letter of Intent for RTO
Syndicated under license via QuoteMedia VANCOUVER, Nov. 14, 2018 /CNW/ - Pivot Pharmaceuticals Inc. (CSE:PVOT / OTCQB:PVOTF / FRA: NPAT) ("Pivot") and Knol Resources Corp. (TSX-V: NOL.H) ("Knol") today announced that they have mutually agreed to terminate the previously announced Letter of ... [Read]
Pivot Pharmaceuticals to Launch Pivot Naturals 1% Oral CBD Solution in European Market
Syndicated under license via Canada News Wire Initial Order of 15,000 Bottles to Be Sold Via Distribution Partner S.T.U. GmbH VANCOUVER, Nov. 14, 2018 /CNW/ - Pivot Pharmaceuticals Inc. (CSE:PVOT / OTCQB:PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased ... [Read]